Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of Gender and HIV Infection on Zidovudine and Lamivudine Pharmacokinetics

This study has been completed.
Sponsor:
Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)
University of Hawaii
Information provided by (Responsible Party):
University of Colorado, Denver
ClinicalTrials.gov Identifier:
NCT01386970
First received: June 28, 2011
Last updated: May 18, 2016
Last verified: May 2016